Alexieva-Figusch J - Search Results

1

Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effects.

Alexieva-Figusch J, Blankenstein MA, Hop WC, Klijn JG, Lamberts SW, de Jong FH, Docter R, Adlercreutz H, van Gilse HA. Alexieva-Figusch J, et al. Eur J Cancer Clin Oncol. 1984 Jan;20(1):33-40. doi: 10.1016/0277-5379(84)90031-2. Eur J Cancer Clin Oncol. 1984. PMID: 6363095 Clinical Trial.

2

Endocrine effects of aminoglutethimide plus hydrocortisone versus effects of high dose of hydrocortisone alone in postmenopausal metastatic breast cancer.

Alexieva-Figusch J, de Jong FH, Lamberts WJ, van Gilse HA, Klign JG. Alexieva-Figusch J, et al. Eur J Cancer Clin Oncol. 1987 Sep;23(9):1349-56. doi: 10.1016/0277-5379(87)90119-2. Eur J Cancer Clin Oncol. 1987. PMID: 2960533

3

Sequential treatment of metastatic breast cancer with tamoxifen after megestrol acetate therapy and vice versa (a retrospective study).

Alexieva-Figusch J, Van Putten WL, van Gilse HA, Blonk-vd Wijst J, Klijn JG. Alexieva-Figusch J, et al. Med Oncol Tumor Pharmacother. 1985;2(2):69-75. doi: 10.1007/BF02934851. Med Oncol Tumor Pharmacother. 1985. PMID: 4058078

4

Endocrine effects of the combination of megestrol acetate and tamoxifen in the treatment of metastatic breast cancer.

Alexieva-Figusch J, Blankenstein MA, de Jong FH, Lamberts SW. Alexieva-Figusch J, et al. Eur J Cancer Clin Oncol. 1984 Sep;20(9):135-40. doi: 10.1016/0277-5379(84)90121-4. Eur J Cancer Clin Oncol. 1984. PMID: 6434315

5

Progestin therapy in advanced breast cancer: megestrol acetate--an evaluation of 160 treated cases.

Alexieva-Figusch J, van Gilse HA, Hop WC, Phoa CH, Blonk-van der Wijst J, Treurniet RE. Alexieva-Figusch J, et al. Cancer. 1980 Dec 1;46(11):2369-72. doi: 10.1002/1097-0142(19801201)46:11<2369::aid-cncr2820461111>3.0.co;2-3. Cancer. 1980. PMID: 7438013

6

Investigations on the nutritional status of advanced breast cancer patients. The influence of long-term treatment with megestrol acetate or tamoxifen.

Schrijver J, Alexieva-Figusch J, van Breederode N, van Gilse HA. Schrijver J, et al. Nutr Cancer. 1987;10(4):231-45. doi: 10.1080/01635588709513961. Nutr Cancer. 1987. PMID: 3432093

7

Steroid receptors in megestrol acetate therapy.

Alexieva-Figusch J, Teulings FA, Hop WC, Blonk-van der Wijst J, van Gilse HA. Alexieva-Figusch J, et al. Recent Results Cancer Res. 1984;91:253-8. doi: 10.1007/978-3-642-82188-2_36. Recent Results Cancer Res. 1984. PMID: 6203149 Clinical Trial. No abstract available.

8

Anti-tumor and endocrine effects of chronic LHRH agonist treatment (Buserelin) with or without tamoxifen in premenopausal metastatic breast cancer.

Klijn JG, de Jong FH, Blankenstein MA, Docter R, Alexieva-Figusch J, Blonk-van der Wijst J, Lamberts SW. Klijn JG, et al. Breast Cancer Res Treat. 1984;4(3):209-20. doi: 10.1007/BF01806487. Breast Cancer Res Treat. 1984. PMID: 6435703 Clinical Trial.

9

Antiprogestins, a new form of endocrine therapy for human breast cancer.

Klijn JG, de Jong FH, Bakker GH, Lamberts SW, Rodenburg CJ, Alexieva-Figusch J. Klijn JG, et al. Cancer Res. 1989 Jun 1;49(11):2851-6. Cancer Res. 1989. PMID: 2720645

10

The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer.

Alexieva-Figusch J, Van Putten WL, Blankenstein MA, Blonk-Van Der Wijst J, Klijn JG. Alexieva-Figusch J, et al. Cancer. 1988 Feb 15;61(4):758-68. doi: 10.1002/1097-0142(19880215)61:4<758::aid-cncr2820610421>3.0.co;2-t. Cancer. 1988. PMID: 3338038

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters